Induction of High Affinity Fibroblast Growth Factor Receptor Expression and Proliferation in Human Endothelial Cells by Anti-HLa Antibodies: A Possible Mechanism for Transplant Atherosclerosis

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5697-5704

  Harris, Paul E ^a   Bian, Hong ^a   Reed, Elaine F ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR; HLA ANTIGEN; HLA ANTIGEN CLASS 1;

ARTERIOSCLEROSIS; ARTICLE; CELL CULTURE; CELL DIVISION; GRAFT REJECTION; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM;

ANTIBODIES; ARTERIOSCLEROSIS; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MUSCLE, SMOOTH; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 0031303670     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Terasaki, P. I., J. D. McClelland, J. Yuge, J. M. Cecka, D. W. Gjertson, S. Takemoto, and Y. W. Cho. 1995. Advances in kidney transplantation: 1985-1995. In Clinical Transplants 1995. J. M. Cecka and P. I. Terasaki, eds. UCLA Tissue Typing Laboratory, Los Angeles, CA, p. 487.
2. Haruhito, A., and N. L. Tilney. 1994. Chronic graft rejection. Curr. Opin. Immunol. 6:770.
3. Paul, L. C., and B. Fellstrom. 1992. Chronic vascular rejection of the heart and kidney: have rational treatment options emerged? Transplantation 53:1169.
4. Hayry, P., H. Isoniemi, S. Yilmaz, A. Mennander, K. Lemstrom, A. Raisanen-Sokolowski, P. Koskinen, J. Ustinov, I. Lautenschlager, E. Taskinen, L. Krogerus, P. Aho, and T. Paavonen. 1993. Chronic allograft rejection. Immunol. Rev. 134:33.
5. Johnson, D. E., S. Z. Gao, J. S. Schroeder, W. M. Decampli, and M. E. Billingham. 1989. The spectrum of coronary artery pathologic findings in human cardiac allografts. J. Heart Transplant. 8:349.
6. Thorogood, J., H. C. van Houwelingen, J. J. van Rood, F. A. Zantvoort, G. M. T. Schreuder, and G. G. Persijn. 1992. Factors contributing to long-term kidney graft survival in Eurotransplant. Transplantation 54:152.
7. Takiff, H., D. J. Cook, N. S. Himaya, M. R. Mickey, and P. I. Terasaki. 1988. Dominant effect of histocompatibility on ten-year kidney transplant survival. Transplantation 45:410.
8. Fenoglio, J., E. Ho, E. Reed, E. Rose, C. Smith, K. Reemstma, C. Marboe, and N. Suciu-Foca. 1989. Anti-HLA antibodies and heart allograft survival. Transplant. Proc. 21:807.
9. Suciu-Foca, N., E. Reed, V. D. D'Agati, E. Ho, D. J. Cohen, A. I. Benvenisty, R. McCabe, J. M. Brensilver, D. W. King, and M. A. Hardy. 1991. Soluble HLA antigens, anti-HLA antibodies and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 51:593.
10. Suciu-Foca, N., E. Reed, C. Marboe, P. Harris, Y. P. Xi, Y. K. Sun, E. Ho, E. Rose, K. Reemtsma, and D. W. King. 1991. The role of anti-HLA antibodies in heart transplantation. Transplantation 51:716.
11. Ende, N., E. V. Orsi, N. Z. Baturay, and T. L. Britten. 1979. Properties of a cytotoxic kidney antibody associated with human renal transplantation. Am. J. Clin. Pathol. 71:543.
12. Duijvestijn, A. M., and P. J. C. Van Breda Vriesman. 1991. Chronic renal allograft rejection: selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation. Transplantation 52:195.
13. Cherry, R., H. Nielsen, E. Reed, K. Reemtsma, N. Suciu-Foca, and C. C. Marboe. 1992. Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J. Heart Lung Transplant. 11:24.
14. Reed, E. F., B. Hong, E. Ho, P. E. Harris, J. Weinberger, and N. Suciu-Foca. 1996. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 61:566.
15. Davenport, A., M. E. Younie, J. E. M. Parsons, and P. T. Klouda. 1994. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection. Nephrol. Dial. Transplant. 9:1315.
16. Costa, A. N., M. P. Scolari, S. Iannelli, A. Buscaroli, G. L. D'Arcangelo, B. Brando, F. Indiveri, M. Savi, L. C. Borgnino, L. B. DeSanctis, S. Stefoni, and V. Bonomini. 1997. The presence of posttranplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies. Transplantation 63:167.
17. Bian, H., P. E. Harris, A. Mulder, and E. F. Reed. 1997. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum. Immunol. 53:90.
18. Decker, S. J., and P. Harris. 1989. Effects of platelet-derived growth factor on phosphorylation of the epidermal growth factor receptor in human skin fibroblasts. J. Biol. Chem. 264:9204.
19. Liu, Z., Y. K. Sun, Y. P. Xi, H. Bian, P. E. Harris, E. F. Reed, and N. Suciu-Foca. 1993. Limited usage of T cell receptor Vβ genes by allopeptide-specific T cells. J. Immunol. 150:3180.
20. Zhao, X. M., W. H. Frist, T. K. Yeoh, and G. G. Miller. 1994. Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection. J. Clin. Invest. 94:992.
21. Rifkin, D. B., and D. Moscatelli. 1989. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1.
22. Kan, M., E. Shi, and W. L. McKeehan. 1991. Identification and assay of fibroblast growth factor receptors. Methods Enzymol. 198:158.
23. Werner, S., D. S. R. Duan, C. de Vries, K. G. Peters, D. E. Johnson, and L. T. Williams. 1992. Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol. Cell. Biol. 12:82.
24. O'Connell, T. X., and J. F. Mowbray. 1973. Arterial intimal thickening produced by alloantibodies and xenoantibody. Transplantation 51:262.
25. Russell, P. S., C. M. Chase, H. J. Winn, and R. B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J. Immunol. 152:5135.
26. Geppert, T. D., L. S. Davis, H. Gur, M. C. Wacholtz, and P. E. Lipsky. 1990. Accessory cell signals involved in T-cell activation. Immunol. Rev. 117:5.
27. Dasgupta, J. D., E. Egea, V. Relias, A. Iglesias, P. Gladstone, and E. J. Yunis. 1990. Involvement of major histocompatibility complex class I antigens in T cell activation. Eur. J. Immunol. 20:1553.
28. Dissing, S., C. Geisler, B. Rubin, T. Plesner, and M. H. Claesson. 1990. T cell activation II. Activation of human T lymphoma cells by cross-linking of their MHC class I antigens. Cell. Immunol. 126:196.
29. Wacholtz, M. C., S. S. Patel, and P. E. Lipsky. 1989. Patterns of costimulation of T-cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules. J. Immunol. 142:4201.
30. Geppert, T. D., M. C. Wacholtz, L. S. Davis, and P. E. Lipsky. 1988. Activation of human T4 cells by cross-linking class I MHC molecules. J. Immunol. 140: 2155.
31. Geppert, T. D., and P. E. Lipsky. 1991. Association of various T cell-surface molecules with the cytoskeleton: effect of cross-linking and activation. J. Immunol. 146:3298.
32. Bregenholt, S., M. Ropke, S. Skov, and M. H. Claesson. 1996. Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypcs and functions. J. Immunol. 157:993.
33. Taylor, D. S., P. C. Nowell, and J. Kornbluth. 1987. Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes. J. Immunol. 139:1792.
34. Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1.
35. 2-terminal immunoglobulin-like loop I in the ectodomain of the fibroblast growth factor (FGF) receptor I lowers affinity for both heparin and FGF-1. J. Biol. Chem. 270:10231.
36. Shi, E., M. Kan, J. Xu, F. Wang, J. Hou, and W. L. McKeehan. 1993. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol. Cell. Biol. 13:3907.
37. Luqmani, Y. A., M. Graham, and R. C. Coombes. 1992. Expression of basic fibroblast growth factor, FGFR1 and FGFR2, in normal and malignant human breast, and comparison with other normal tissue. Br. J. Cancer 66:273.
38. Kerby, J. D., D. J. Verran, K. L. Luo, Q. Ding, Y. Tagouri, G. A. Herrera, A. G. Diethelm, and J. A. Thompson. 1996. Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection. Transplantation 62:467.
39. Hansen, N. Q., T. Tscherning, and M. H. Claesson. 1990. T-cell activation. IV. Evidence for a functional linkage between MHC class I, IL-2 and IL-4 receptor molecules. Cytokine 3:35.
40. Geppert, T. D., M. C. Wacholtz, S. S. Patel, E. Lightfoot, and P. E. Lipsky. 1989. Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules. J. Immunol. 142:3763.
41. Heldin, C. H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213.
42. Gur, H., F. El-Zaatari, T. D. Geppert, M. C. Wacholtz, J. D. Taurog, and P. E. Lipsky. 1990. Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction. J. Exp. Med. 172: 1267.
43. Due, C., M. Simonsen, and L. Olsson. 1986. The major histocompatibility complex class 1 heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biologic functions of histocompatibility antigens. Proc. Natl. Acad. Sci. USA 83:6007.
44. Phillips, M. L., M. L. Moule, T. L. Delovitch, and C. C. Yip. 1986. Class I histocompatibility antigens and insulin receptors: evidence for interactions. Proc. Natl. Acad. Sci. USA 83:3474.
45. Samson, M., J. L. Cousin, and M. Fehlmann. 1986. Cross-linking of insulin receptors to MHC antigens in human B lymphocytes: evidence for selective molecular interactions. J. Immunol. 137:2293.
46. Schrieber, A. B., J. Schlessinger, and M. Edidin. 1984. Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells. J. Cell. Biol. 98:725.
47. Skov, S., N. Odum, and M. H. Claesson. 1995. MHC class I signaling in T cells leads to tyrosine kinase activity and PLC-γ1 phosphorylation. J. Immunol. 154: 1167.
48. Mohammadi, M., I. Dikic, A. Sorokin, W. H. Burgess, M. Jaye, and J. Schlessinger. 1996. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:977.
49. Hsu, H. Y., A. C. Nicholson, and D. P. Hajjar. 1994. Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression: signal transduction pathways mediated by the bFGF receptor tyrosine kinase. J. Biol. Chem. 269:9213.
50. Rekhter, M. D., and D. Gordon. 1995. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am. J. Pathol. 147: 668.
51. Wagner, C. R., T. E. Morris, G. D. Shipley, and J. D. Hosenpud. 1993. Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro: a potential mechanism for cardiac allograft vasculopathy. J. Clin. Invest. 92:1269.